Neuromodulation to Facilitate the Effect of Ketamine

Completed

• Conditions: Depression; Chronic Pain; Substance Abuse

• Registration Number: NCT01816958
• Lead Sponsor: The Neuroscience Center, LLC

Brief Summary

application of external neuromodulation along with ketamine infusion.

Detailed Description

apply TMS concurrent with ketamine infusion in order to increase the likliehood \& strength of therapeutic benefit

Study Timeline

• Study Start: 2011-01
• Primary Completion: 2012-11
• Study Completion: 2012-11
• Status Verified: 2013-03
• Study First Submitted: 2013-03-11
• Study First Submitted QC: 2013-03-20
• Last Update Submitted: 2013-03-20
• Study First Posted: 2013-03-22
• Last Update Posted: 2013-03-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

• chronically ill,
• treatment-resistant

Exclusion Criteria

• active psychosis

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Global Assessment of Function in DSM-4R	up to 3 years	treat in order to cause remission of disability

Trial Locations

Locations (1)

The Neuroscience Center; 🇺🇸 Deerfield, Illinois, United States